A Distributed Regression Analysis Application Package Using SAS Read more about A Distributed Regression Analysis Application Package Using SAS
Drugs with Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) & Utilization Read more about Drugs with Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU)
Utilization of Methotrexate: A Descriptive Analysis in TriNetX Read more about Utilization of Methotrexate: A Descriptive Analysis in TriNetX
A Simple Cox Approach to Estimating Risk Ratios Without Sharing Individual-Level Data in Multi-Site Studies Read more about A Simple Cox Approach to Estimating Risk Ratios Without Sharing Individual-Level Data in Multi-Site Studies
Predicting Causes of Death from Structured Electronic Health Records Using Machine Learning Read more about Predicting Causes of Death from Structured Electronic Health Records Using Machine Learning
High-Dimensional Multiple Imputation (hdMI) Strategies for Partially Observed Confounders with Structured and Natural Language Processing-Derived Auxiliary Covariates Read more about High-Dimensional Multiple Imputation (hdMI) Strategies for Partially Observed Confounders with Structured and Natural Language Processing-Derived Auxiliary Covariates
Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Dependent Glucose Co-Transporter 2 Inhibitors in the FDA Sentinel System Read more about Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Dependent Glucose Co-Transporter 2 Inhibitors in the FDA Sentinel System
Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis Read more about Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis
Utilization of Ibrexafungerp in Pregnant Women: An Updated Descriptive Analysis Read more about Utilization of Ibrexafungerp in Pregnant Women: An Updated Descriptive Analysis
Intentional Self-Harm Algorithm Defined in "Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis" Read more about Intentional Self-Harm Algorithm Defined in "Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis"